Results 41 to 50 of about 65,573 (238)

Organizing the interface—Plasma membrane architecture and receptor dynamics in virus‐cell interactions

open access: yesFEBS Letters, EarlyView.
Plasma membranes contain dynamic nanoscale domains that organize lipids and receptors. Because viruses operate at similar scales, this architecture shapes early infection steps, including attachment, receptor engagement, and entry. Using influenza A virus and HIV‐1 as examples, we highlight how receptor nanoclusters, multivalent glycan interactions ...
Jan Schlegel, Christian Sieben
wiley   +1 more source

Tragedija slovenskega nacionalnega patentnega sistema

open access: yesEconomic and Business Review, 2019
The current Slovenian national patent system is supposed to provide incentives for innovation activity in the Slovenian economy while preventing the granting of unjustified monopolies, but the question arises whether this is the case.
Mitja Kovač, Rok Spruk
doaj   +1 more source

Epigenetic blind spots – the role of DNA methylation dynamics in stem cell‐based models of embryogenesis

open access: yesFEBS Letters, EarlyView.
Embryo‐like structures (stembryos) are an innovative tool, but they are hindered by experimental variability and limited developmental potential. DNA methylation is crucial for mammalian development, but its status in stembryo models is poorly characterized.
Sara Canil   +4 more
wiley   +1 more source

Patenting in Europe: The Jurisdiction of the CJEU over European Patent Law

open access: yesPerspectives on Federalism, 2015
This paper will deal with EU competence over patent law, especially in the context of the TRIPS Agreement with reference to the ruling of CJEU in the Daiichi Sankyo case (CJEU case C-414/11 Daiichi Sankyo v DEMO Anonimos). The first part will explain the
Minn Mari
doaj   +1 more source

Modulation of Homer1 EVH1 domain internal dynamics by putative autism‐associated mutations

open access: yesFEBS Letters, EarlyView.
The putative autism‐associated M65I and S97L variants of the EVH1 domain of the postsynaptic scaffold protein Homer1 do not exhibit substantial changes in their overall structure or partner binding. Both of them, but especially the M65I variant, show altered internal dynamics relative to the wild‐type domain on the μs‐ms timescale, indicated by the ...
Fanni Farkas   +6 more
wiley   +1 more source

Interfacing of science, medicine and law: The stem cell patent controversy in the United States and the European Union

open access: yesFrontiers in Cell and Developmental Biology, 2015
The patent eligibility of stem cells – particularly those derived from human embryos – has long been under debate in both the scientific and legal communities.
Sonya eDavey   +11 more
doaj   +1 more source

Microbiome−host proteostasis crosstalk—An emerging perspective on mechanisms and interventions toward healthy longevity

open access: yesFEBS Letters, EarlyView.
Proteostasis and the gut microbiota play a key role in shaping host physiology. Microbiota‐derived metabolites, vitamins, and RNA modulate host proteostasis. Findings from model systems, including C. elegans, indicate microbes can either stabilize or disrupt host proteostasis.
Abhishek Anil Dubey, Maria Ermolaeva
wiley   +1 more source

Mixed‐class J‐domain protein scaffolds promote expanded aggregate handling and multivalent Hsp70 engagement during functional disaggregase assembly

open access: yesFEBS Letters, EarlyView.
Protein aggregates threaten proteostasis and cell health. In human cells, Hsp70–J‐domain protein‐based disaggregases remove aggregates, but how they assemble remains unclear. Our biochemical findings show that DNAJA2‐ and DNAJB1‐containing disaggregase scaffolds enhance luciferase aggregate targeting, and that Hsp70 recruitment by both J‐domain ...
Anna Szlachcic, Nadinath B. Nillegoda
wiley   +1 more source

Is Poland an Innovative Country?

open access: yesManagement Systems in Production Engineering, 2018
The potential for innovativeness is difficult to measure, though many have attempted to do so. In order to look at Poland’s innovation potential, its current position and its opportunity to grow, compared with developing and developed countries, this ...
Chybowska Dorota   +2 more
doaj   +1 more source

Brexit – What are the potential consequences for pharma patents and SPCs

open access: yesBritish Journal of Pharmacy, 2017
Brexit raises a number of difficult questions with regard to intellectual property rights in a post-Brexit world, particularly for UK based pharma companies.
Jamie Fraser, James Stones
doaj   +1 more source

Home - About - Disclaimer - Privacy